Home » Topics » BioWorld Science

BioWorld Science
RSS

Results from GLP preclinical study of AAV8-hCocH gene therapy

Jan. 22, 2020

TMPRSS11B as a new therapeutic target in NSCLC

Jan. 22, 2020

FDA clears IND application for KAN-101 for the treatment of celiac disease

Jan. 22, 2020

Initiation of first-in-human study of SBT-272

Jan. 22, 2020

Young blood not all it's cracked up to be

Jan. 22, 2020

African Americans' lung tumors have unstable genomes

Jan. 22, 2020

GM1 soluble oligosaccharide shows therapeutic potential for sporadic PD in B4galnt1+/- mice

Jan. 22, 2020

AAV-ABCB4 gene therapy causes sustained reversal of PFIC3 disease biomarkers in mice

Jan. 22, 2020

LB Pharmaceuticals begins phase I study of LB-102 for schizophrenia

Jan. 21, 2020

Candidate rabies vaccine ChAdOx2 RabG begins first-in-human study

Jan. 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...